mementor develops and markets digital medical products in sleep medicine and related fields. Originally founded in 2014 in Switzerland by Dr. Noah Lorenz, Alexander Rötger, Jan Kühni, and Daniel Rotzetter, mementor has had its headquarters in Leipzig since January 2020. mementor focuses with its "Apps on Prescription" where conventional patient care reaches its limits. The goal is to eliminate treatment barriers and provide affected individuals access to evidence-based therapy methods.

Our team aims to provide affected individuals with effective tools through its digital health products to treat physical or mental illnesses effectively. At the same time, we want to help close the existing gaps in healthcare and shape the future of digital medicine. High scientific standards, an evidence-based approach, the highest data protection requirements, and patient safety are paramount.

Both information security and patient safety are priorities at mementor. mementor is certified according to the DIN EN ISO/IEC 27001 standard and meets all related information security requirements. The certification of the quality management system according to DIN EN ISO 13485 demonstrates that mementor takes all prescribed measures to manufacture high-quality medical devices. Compliance with the requirements of both standards is demonstrated annually through internal and external audits to ensure the highest quality and safety.

Since August 2nd, 2022, mementor DE GmbH has been part of ResMed in Germany. Together, they aim to leverage their respective expertise and learn from each other to provide more people with effective and low-threshold access to alternative therapy options for sleep disorders and close care gaps. ResMed, as a leading provider of therapy for sleep-related breathing disorders and respiratory diseases in outpatient care, expands its portfolio in digital sleep medicine with this acquisition. mementor is integrated as a separate division of ResMed in Germany and serves as a basis for future developments in digital health. The founder Dr. Noah Lorenz and Katherina Jekerle, previously Senior Director Marketing and member of ResMed Germany's management, will take over the management jointly.

With somnio, developed with sleep medicine specialists and psychologists, mementor created the first permanently approved DiGA (app on prescription) since October 2020 for the treatment of sleep-onset and sleep-maintenance disorders (insomnia). The app's content is based on cognitive behavioral therapy for insomnia (CBT-I), translated into various modules for somnio. The app allows for personalized adjustments based on user input and sustainably improves sleep behavior within three months. The effectiveness of somnio has been proven by a randomized scientific study showing positive care effects.